Risperidona: diferència entre les revisions

Contingut suprimit Contingut afegit
m preposició
Robot canvia de Drugbox a Infotaula fàrmac
Línia 1:
{{Infotaula fàrmac}}
{{drugbox | verifiedrevid = 464382756
| IUPAC_name = 4-[2-[4-(6-fluorobenzo[''d'']isoxazol-3-yl)-<br>1-piperidyl]ethyl]-3-methyl-<br>2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one
| image = Risperidone.svg
| image2 = Risperidone-3D-balls.png
 
<!--Clinical data-->
| tradename = Risperdal
| Drugs.com = {{drugs.com|monograph|risperidone}}
| MedlinePlus = a694015
| pregnancy_category = C
| legal_status = Rx-only
| routes_of_administration = Oral and extended-release intramuscular injection
 
<!--Pharmacokinetic data-->
| bioavailability = 70% (oral)
| metabolism = Hepatic ([[CYP2D6]]-mediated)
| elimination_half-life = 20 hours
| excretion = Urinary
 
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 106266-06-2
| ATC_prefix = N05
| ATC_suffix = AX08
| PubChem = 5073
| IUPHAR_ligand = 96
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00734
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4895
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = L6UH7ZF8HC
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00426
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8871
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 85
 
<!--Chemical data-->
| C=23 | H=27 | F=1 | N=4 | O=2
| molecular_weight = 410.485 g/mol
| smiles = Cc1c(c(=O)n2c(n1)CCCC2)CCN3CCC(CC3)c4c5ccc(cc5on4)F
| InChI = 1/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RAPZEAPATHNIPO-UHFFFAOYSA-N
}}
La '''risperidona''' és una [[principi actiu]] comercialitzat sota la marca '''risperdal'''™. És un [[medicament]] [[antipsicòtic]] indicat per a tractar l'[[esquizofrènia]]. És disponible en [[pastilla|pastilles]] i també en format Flash bucodispersable i Consta injectable quinzenal. Pertany als antipsicòtics de segona generació. El fabrica la farmacèutica [[Janssen-Cilag]] i també altres farmacèutiques com a genèric.